Head-to-Head

BillionToOne, Inc. Class A Common Stock vs. Quest Diagnostics Inc.

BLLN

BillionToOne, Inc. Class A Common Stock

$91.65 -38.89%

VS DGX

Quest Diagnostics Inc.

$238.50 +1.13%

Quest Diagnostics Inc. (DGX) comes out ahead, leading on 8 of 9 compared factors.

Size & Scale

BLLNDGX
Market Cap $4.32 billion $26.32 billion
Revenue (TTM) $397.41 million $11.56 billion
Net Income (TTM) $37.71 million $1.11 billion

DGX leads on 3 of 3 size & scale factors.

Valuation

BLLNDGX
P/E Ratio 88.98 25.32
Price / Book 8.06 3.37
Price / Sales 10.88 2.28

DGX leads on 3 of 3 valuation factors.

Profitability

BLLNDGX
Net Margin 9.49% 9.63%
Return on Equity 7.03% 14.23%

DGX leads on 2 of 2 profitability factors.

Dividend

BLLNDGX
Dividend Yield — 1.44%
Payout Ratio — 36.52

BLLN and DGX split the dividend factors evenly.

Risk & Sentiment

BLLNDGX
Short Interest 0.13% 4.76%

BLLN leads on 1 of 1 risk & sentiment factors.

Dig deeper: BLLN overview, BLLN financials, DGX overview, DGX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.